| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $63.65 | $63,650.00 | -3.0% | |
| Jun 21, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $63.62 | $2,521,627.74 | -0.3% | |
| Jun 18, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $58.19 | $232,760.00 | -14.4% | |
| Jun 14, 2018 | Yu K Peony | Chief Medical Officer | Sell | 3,422 | $59.20 | $202,582.40 | -2.3% | |
| Jun 14, 2018 | Cotroneo Pat | SVP, Finance And CFO | Sale+OE | 10,069 | $59.47 | $598,806.30 | -2.2% | |
| Jun 11, 2018 | Routti Jorma | Director | Sale+OE | 6,000 | $57.48 | $344,880.00 | -4.4% | |
| Jun 8, 2018 | Cotroneo Pat | SVP, Finance And CFO | Sell | 1,011 | $55.55 | $56,161.05 | -0.4% | |
| Jun 5, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $54.86 | $2,174,597.10 | -0.3% | |
| Jun 4, 2018 | Cotroneo Pat | SVP, Finance And CFO | Sale+OE | 6,013 | $55.16 | $331,677.08 | -2.5% | |
| May 21, 2018 | Cotroneo Pat | SVP, Finance And CFO | Sale+OE | 14,987 | $55.04 | $824,884.48 | -6.1% |